查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白質工程市場 - 2023-2030年
市場調查報告書
商品編碼
1289777

全球蛋白質工程市場 - 2023-2030年

Global Protein Engineering Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球蛋白質工程市場在2022年達到22.472億美元，預計到2030年將見證有利可圖的成長，達到67.213億美元。在預測期間（2023-2030年），全球蛋白質工程市場預計將呈現15.2%的複合成長率。

蛋白質工程是改變或開發蛋白質的過程，以改善現有特性或增加額外功能。它還需要對蛋白質的結構、序列和特性進行修補，以提高其穩定性、特異性、活性和其他理想的特徵。

由於技術的發展，對基於蛋白質的藥品需求的增加，以及蛋白質在許多領域的用途的擴大，全球蛋白質工程市場正在迅速發展。

市場動態

對基於蛋白質的藥物的需求不斷成長，預計將推動全球蛋白質工程市場的發展

全球蛋白質工程市場的主要驅動力之一是隨著糖尿病發病率的上升，對基於蛋白質的治療藥物的需求不斷增加。根據CDC的2022年全國糖尿病統計報告，美國有3730萬人患有糖尿病，佔總人口的11.3%。

由於美國糖尿病發病率的上升，預計對胰島素以及蛋白工程人工胰島素的需求將上升。因此，由於上述因素，全球蛋白質工程市場將在預測期內得到提升。

全球蛋白質工程市場可能會因儀器的高成本而面臨制約因素

蛋白質工程需要利用先進的工具和設備，如質譜儀、色譜系統和高通量篩選平台。這類設備的購買、維護和改進都很昂貴。

儀器的高成本是投資蛋白質工程技術的一個障礙，特別是對於資源有限的中小型企業（SME）或研究機構。由於這個原因，全球蛋白質工程市場在預測期內將面臨一個主要的阻礙因素。

COVID-19的影響分析

COVID-19大流行病對蛋白質工程業務產生了實質性的影響，對治療和診斷的需求增加推動了研究和開發活動。蛋白質工程方法已被用於疫苗開發、抗病毒藥物設計和診斷測試開發。

合作、融資以及研究重點轉向病毒蛋白和免疫反應，推動了蛋白質工程的進步。然而，供應鏈的中斷也帶來了困難。總的來說，這場大流行強調了蛋白質工程在解決全球健康問題方面的重要性，並推動了該領域的創新。

俄羅斯-烏克蘭衝突分析

俄羅斯和烏克蘭之間的戰爭對全球蛋白質工程行業的直接影響有限。然而，間接的影響，如供應鏈中斷、經濟不穩定、研究合作緊張、人才遷移和監管變化/貿易壁壘都是可能的。

這些因素可能對資源可用性、投資決策、研究資金、科學發展和全球蛋白質工程的人才庫產生影響。然而，必須強調的是，地緣政治衝突只是影響該行業的幾個變量之一，科學發展和市場需求具有更大的影響。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品類型分類的市場簡述
  • 按蛋白質類型分類的市場分析
  • 按技術分類的市場分析
  • 按終端用戶分類的市場分析
  • 按地區分類的市場分析

第四章：動態變化

  • 影響因素
    • 驅動因素
      • 對蛋白質類藥物的需求不斷成長
    • 限制因素
      • 儀器的高成本
    • 機會
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第七章：按產品類型

  • 耗材
  • 儀器
  • 軟體和服務

第8章：按蛋白質類型分類

  • 胰島素
  • 促紅細胞生成素
  • 疫苗
  • 干擾素
  • 凝血因子
  • 菌落刺激因子
  • 生長激素
  • 單克隆抗體

第9章：按技術分類

  • 非理性的蛋白質設計
  • 合理的蛋白質設計

第十章：按終端用戶分類

  • 生物製藥公司
  • 契約研究組織
  • 其他

第十一章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第十二章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十三章：公司簡介

  • GE Healthcare
    • 公司概述
    • 產品組合和說明
    • 財務概況
    • 主要發展情況
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Genscript Biotech Corporation
  • Codexis, Inc.
  • Waters Corporation
  • New England Biolabs, Inc.
  • Merck KGaA

第十四章：附錄

簡介目錄
Product Code: BT2684

Market Overview

The Global Protein Engineering Market reached US$ 2,247.2 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 6,721.3 million by 2030. The global protein engineering market is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030).

Protein engineering is the process of altering or developing proteins in order to improve existing characteristics or add additional functionality. It also entails tinkering with protein structure, sequence, and characteristics in order to increase their stability, specificity, activity, and other desirable traits.

The global protein engineering market is developing rapidly as a result of technological developments, rising demand for protein-based pharmaceuticals, and the expanding uses of proteins in numerous sectors.

Market Dynamics

The Growing Demand for Protein Based Drug is Expected to Drive the Global Protein Engineering Market

One of the major drivers of the worldwide protein engineering market is the increasing need for protein-based therapeutics as the frequency of diabetes rises. According to the CDC's National Diabetes Statistics Report for 2022, 37.3 million people in the United States have diabetes, accounting for 11.3% of the total population.

Because of the rising prevalence of diabetes in the United States, demand for insulin, as well as protein-engineered artificial insulin, is predicted to rise. Therefore, owing to the above factor the global protein engineering market will boost over the forecast period.

The Global Protein Engineering Market May Face Constraints due to the High Cost of Instruments

Protein engineering requires the utilization of advanced tools and equipment such as mass spectrometers, chromatography systems, and high-throughput screening platforms. Such equipment can be costly to buy, maintain, and improve.

The high cost of instruments is a barrier to investment in protein engineering technologies, particularly for small and medium-sized firms (SMEs) or research institutes with restricted resources. Owing to this reason the global protein engineering market will face a major restraint over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a substantial influence on the protein engineering business, with increasing demand for treatments and diagnostics driving research and development activities. Protein engineering approaches have been used in vaccine development, antiviral medication design, and diagnostic test development.

Collaboration, financing, and a shift in research focus to viral proteins and immunological responses have propelled advances in protein engineering. However, supply chain interruptions have presented difficulties. Overall, the pandemic has highlighted the relevance of protein engineering in tackling global health issues and has fueled innovation in the area.

Russia-Ukraine Conflict Analysis

The war between Russia and Ukraine has had a limited direct influence on the global protein engineering industry. However, indirect repercussions such as supply chain disruptions, economic instability, strained research collaborations, talent migration, and regulatory changes/trade barriers are possible.

These factors may have an impact on resource availability, investment decisions, research funding, scientific development, and the global talent pool in protein engineering. However, it is vital to highlight that geopolitical conflicts are only one of several variables influencing the industry, with scientific developments and market demand having a larger impact.

Segment Analysis

The global protein engineering market is segmented based on product type, protein type, technology, end user, and region.

The Biopharmaceutical Companies Segment is Expected to Dominate the Global Protein Engineering Market

The biopharmaceutical companies segment is projected to dominate the protein engineering market and will account for the highest market share of 52.5%, due to the high proportion utilization of in silico drug research models for treating diabetes, cancer, and neurological illnesses. For example, top pharmaceutical firms such as Novo Nordisk, AstraZeneca, and Eli Lilly have prioritized revenue growth through the discovery of novel treatments.

Furthermore, the biopharmaceutical companies segment is expanding due to increased financing and investment assistance from both public and private healthcare organizations. For instance, in March 2023, Sanofi's acquisition of Provention Bio brought a new, first-in-class medication for type 1 diabetes to its general medicines core asset portfolio. Therefore, the adoption of in-silico techniques and an increase in funding will drive the segment growth of the global protein engineering market size over the forecast period.

Geographical Analysis

North America Region Holds the Largest Market Share of the Global Protein Engineering Market

The global protein engineering market is dominated by North America and holds 2/5th market share due to better healthcare spending, technological advancements, presence of major market players leading to drug development, collaboration, and advanced healthcare infrastructure.

For instance, in January 2023. Proteinea, a biotech startup based in the U.S. and Egypt, is pioneering computational protein engineering technology, as they are releasing Ankh, the most sophisticated and high-performing open-source protein language model in the world. Proteinea created Ankh in collaboration with Google and the Technical University of Munich, using funding from Google's cloud innovators program.

Competitive Landscape

The major global players in the market include: GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, Genscript Biotech Corporation, Codexis, Waters Corporation, New England Biolabs, and Merck KGaA.

Why Purchase the Report?

  • To visualize global protein engineering market segmentation based on product type, protein type, technology, end user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global protein engineering market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global protein engineering market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Protein Type
  • 3.3. Market Snippet by Technology
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The growing demand for protein-based drug
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of instruments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Consumables
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Instruments
  • 7.4. Software & Services

8. By Protein Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 8.1.2. Market Attractiveness Index, By Protein Type
  • 8.2. Insulin
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Erythropoietin
  • 8.4. Vaccines
  • 8.5. Interferons
  • 8.6. Coagulation Factors
  • 8.7. Colony-Stimulating Factors
  • 8.8. Growth Hormones
  • 8.9. Monoclonal Antibodies

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Irrational Protein Design
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Rational Protein Design

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Biopharmaceutical Companies*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Contract Research Organizations
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Thermo Fisher Scientific, Inc.
  • 13.3. Agilent Technologies, Inc.
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. Bruker Corporation
  • 13.6. Genscript Biotech Corporation
  • 13.7. Codexis, Inc.
  • 13.8. Waters Corporation
  • 13.9. New England Biolabs, Inc.
  • 13.10. Merck KGaA

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us